跳至主要内容
临床试验/CTRI/2024/10/075852
CTRI/2024/10/075852招募中不适用

A COMPARATIVE CLINICAL STUDY ON THE EFFICACY OF YOGOTTAMA GUTIKA(ORALLY) WITH OR WITHOUT GOKSHURA TAILA MATRA VASTI IN THE MANAGEMENT OF KATI GRAHA W.S.R TO INTER VERTEBRAL DISC PROLAPSE

Dr Baliga Ashok Kumar1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年11月15日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40
试验地点
1
主要终点
1. To assess the efficacy of Yogottama Gutika(orally) and Gokshura taila Matra Vasti in the management of Kati Graha w.s.r. to Inter-Vertebral disc prolapse[I V D P].

研究概览

简要总结

Study design: open labelled COMPARATIVE clinical trail

Number of groups: TWO [Group- A and Group- B]

  • In the present study, it has been proposed to include 40 patients of diagnosed with Kati Graha between the age group of 20 - 60 years, selected and placed in two groups A and B pertaning to the therapy schedule.

  • 20 patients of group A will be treated with Yogottama Gutika (orally) only and 20 patients of group B will be treated with Drug Yogottama Gutika (orally) along with Gokshura taila Matra Vasti(internally).

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • 1 Patient who are presenting with signs and symptoms of Kati Graha 2 Patients who are diagnosed with Inter-vertebral disc prolapse.
  • 3 Patients who are willing to participate in study and who signed the consent from.
  • 4 Patients who can come for review and follow up regularly.

排除标准

  • 1 Patients who are contraindicated for Vasti karma.
  • 2 H/O hypersensitivity to the trail drug or any of its ingredients.
  • 3 Patients having infective conditions of spine like T.B of spine etc.
  • 4 Patients having chronic ankylosing spondylosis, spinabifida.
  • 5 Patients having abhigatajanya Kati graha.
  • 6 Patients with evidence of malignancy.
  • 7 Patients with uncontrolled Diabetes mellitus and uncontrolled Hypertension.
  • 8 Patients with unstable Cardio vascular disease.
  • 9 Patients suffering from other major systemic illness necessitating long term drug treatment.
  • 10Patients with concurrent serious hepatic disorder or Renal disorder.

结局指标

主要结局

1. To assess the efficacy of Yogottama Gutika(orally) and Gokshura taila Matra Vasti in the management of Kati Graha w.s.r. to Inter-Vertebral disc prolapse[I V D P].

时间窗: 6months

次要结局

  • 1.To provide comprehensive, effective care in Kati Graha.

研究者

发起方
Dr Baliga Ashok Kumar
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Baliga Ashok Kumar

Dr Brkr government ayurvedic college

研究点 (1)

Loading locations...

相似试验